Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Share-based Compensation (2025 - 2026)

MDxHealth has reported Share-based Compensation over the past 2 years, most recently at $562000.0 for Q1 2026.

  • For Q1 2026, Share-based Compensation rose 43.73% year-over-year to $562000.0; the TTM value through Dec 2025 reached $19.3 million, changed N/A, while the annual FY2025 figure was $19.3 million, 1020.87% up from the prior year.
  • Share-based Compensation was $562000.0 for Q1 2026 at MDxHealth, down from $19.3 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $19.3 million in Q4 2025 and bottomed at $391000.0 in Q1 2025.